Navigation Links
Anadys Pharmaceuticals Reports Third Quarter 2010 Financial Results and Highlights
Date:11/8/2010

SAN DIEGO, Nov. 8, 2010 /PRNewswire-FirstCall/ -- Anadys Pharmaceuticals, Inc. (Nasdaq: ANDS), a biopharmaceutical company dedicated to improving patient care by developing novel medicines for the treatment of hepatitis C, today reported its financial results and program highlights for the third quarter ended September 30, 2010.

"With an enhanced cash position from our recent equity financing, we are now positioned to further advance ANA598, our direct acting antiviral being developed for the treatment of hepatitis C," said Steve Worland, Ph.D., President and CEO of Anadys.  "We are currently finalizing preparations for a Phase IIb study of ANA598 in combination with current standard of care in treatment-naïve and treatment-experienced patients.  The Phase IIb study design is intended to support a broad range of potential treatment opportunities in future Phase III studies.  We also plan to augment our HCV development pipeline in the first half of next year by initiating a Phase IIa study of ANA773, our oral inducer of endogenous interferons."  

Financial ResultsAs of September 30, 2010, the Company's cash, cash equivalents and securities available-for-sale totaled $18.9 million compared to $20.5 million as of December 31, 2009.  The decrease in cash, cash equivalents and securities available-for-sale reflects year-to-date cash utilization of $13.0 million to fund operations, including external expenditures associated with the Phase IIa combination study of ANA598, offset by the receipt of net proceeds of $11.4 million from the Company's "registered direct" offering completed in June 2010.  Including the estimated net proceeds of $23.3 million from the Company's underwritten public offering completed in October 2010 and the $0.5 million grant the Company was awarded under the U.S. government's Qualifying Therapeutic Discovery Proj
'/>"/>

SOURCE Anadys Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Anadys Pharmaceuticals Presents Preclinical Results on ANA598, a Non-Nucleoside Inhibitor of the NS5B Polymerase, at the 14th International Symposium on Hepatitis C Virus and Related Viruses
2. Anadys Pharmaceuticals Announces Positive Results for ANA598 in Animal Model of Chronic Hepatitis C Virus Infection
3. Anadys Pharmaceuticals Presents Data on ANA598, a Non-Nucleoside Inhibitor of the HCV Polymerase, at the 21st International Conference on Antiviral Research
4. Anadys Pharmaceuticals Initiates Phase I Clinical Trial of ANA598
5. Anadys Pharmaceuticals Resumes Clinical Investigation of TLR7 Mechanism in HCV
6. Anadys Pharmaceuticals Announces Successful Outcome of ANA598 Healthy Volunteer Study and Finalization of Study Design for Phase Ib Trial in HCV Patients
7. Anadys Pharmaceuticals to Present at the JMP Securities Healthcare Focus Conference
8. Anadys Pharmaceuticals Announces Single Dose Safety and Pharmacokinetics Results for ANA598 in Healthy Volunteers
9. Anadys Pharmaceuticals Commences Dosing in Phase II Study of ANA598
10. Anadys Pharmaceuticals to Present at Two Upcoming Investor Conferences
11. Anadys Pharmaceuticals to Present at the Oppenheimer Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... -- UnaliWear announces the market preview of its first wearable ... against wandering and provides support for falls and medication ... Kanega watch ( http://www.UnaliWear.com ) – is also the ... interface rather than buttons, use cellular and Wi-Fi technology, ... The watch goes wherever the wearer goes 24/7, ...
(Date:3/3/2015)... WAYNE, N.J. , March 3, 2015 ... USA announced today a new, integrated ... new portable solution is now available with a larger ... integrated console mounted system offers a larger viewing area ... console now provides additional space for accessories and storage, ...
(Date:3/3/2015)... , March 3, 2015 ... today recognized world-class manufacturing companies and individual ... Leadership Awards. Logo - ... of intensifying global competition and accelerating, technology-driven ... distinguished themselves by embracing breakthrough innovation and ...
Breaking Medicine Technology:UnaliWear's Wearable For Seniors Extends Independence With Advanced Technology 2Konica Minolta Medical Imaging and Shimadzu Medical Systems USA Introduce MobileArt Evolution EFX AeroDR-i with 17" Touch Monitor to Simplify Operation 2Konica Minolta Medical Imaging and Shimadzu Medical Systems USA Introduce MobileArt Evolution EFX AeroDR-i with 17" Touch Monitor to Simplify Operation 32015 Manufacturing Leadership Award Winners Announced 22015 Manufacturing Leadership Award Winners Announced 32015 Manufacturing Leadership Award Winners Announced 42015 Manufacturing Leadership Award Winners Announced 52015 Manufacturing Leadership Award Winners Announced 6
... , SAN FRANCISCO, Sept. 23 ... demonstrate that the company,s Combo Bio-engineered Sirolimus Eluting Stent (Combo ... eluting stent and the XIENCE(TM) V everolimus eluting stent. ... tomography (OCT) data out to 28 days show that the ...
... BERLIN, September 23 , ... Data,Which Highlight Benefits of Adding capecitabine to epirubicin and docetaxel,in ... the ABCSG-24 study presented today at the joint 15th ECCO ... to anthracycline- and taxane-containing regimens prior to surgery,(neoadjuvant therapy) completely ...
Cached Medicine Technology:Pre-clinical Data Show OrbusNeich's Combo Bio-engineered Sirolimus Eluting Stent May Offer Advantages to Current Drug Eluting Stent Technologies 2Pre-clinical Data Show OrbusNeich's Combo Bio-engineered Sirolimus Eluting Stent May Offer Advantages to Current Drug Eluting Stent Technologies 3Capecitabine Added to Standard Treatment Given Before Surgery Helps to Eradicate Tumours in Patients With Early Breast Cancer 2Capecitabine Added to Standard Treatment Given Before Surgery Helps to Eradicate Tumours in Patients With Early Breast Cancer 3Capecitabine Added to Standard Treatment Given Before Surgery Helps to Eradicate Tumours in Patients With Early Breast Cancer 4Capecitabine Added to Standard Treatment Given Before Surgery Helps to Eradicate Tumours in Patients With Early Breast Cancer 5
(Date:3/3/2015)... The report “Alopecia – Pipeline Review, H1 2015? ... Alopecia is the loss of hair. Alopecia areata and ... Causes for alopecia include aging, genetics, illness, chemotherapy, malnutrition ... pattern hair loss, female diffuse hair loss, hairs easily ... focal or diffuse and by the presence or absence ...
(Date:3/3/2015)... 03, 2015 US Air Purifiers LLC ... purification systems, is pleased to announce that all Rabbit brand ... interruption related to the west coast port strikes. This news ... the corner. , The port strikes, which ... slow fourth quarter economic growth by as much as 1%, ...
(Date:3/3/2015)... Daylight Savings Time may lead to your kids to ... parents. , Parents and their children may feel a bit ... set their clocks forward one hour for Daylight Savings Time. ... hour earlier -- you will have already lost one hour ... “sleep hygiene” for their kids and teens this week, says ...
(Date:3/3/2015)... Rhinebeck, NY (PRWEB) March 03, 2015 Topical ... held as a webinar streamed live on Tuesday, March 10th, ... workshops will be archived and accessible 24/7. ... the public. The topic for the March 10th workshop is ... timely discussion, considering that the U.S. represents 5% of the ...
(Date:3/3/2015)... Today is International Ear Care Day, ... occasion to applaud and promote the launch of Make ... Organization (WHO) for stemming the threat of noise-induced hearing ... people to practice safe listening when they recreate, be ... sporting events, or engaging in other forms of entertainment. ...
Breaking Medicine News(10 mins):Health News:Alopecia Therapeutics Drugs and Companies Pipeline Market H1 2015 Review Report Available at RnRMarketResearch.com 2Health News:Alopecia Therapeutics Drugs and Companies Pipeline Market H1 2015 Review Report Available at RnRMarketResearch.com 3Health News:Alopecia Therapeutics Drugs and Companies Pipeline Market H1 2015 Review Report Available at RnRMarketResearch.com 4Health News:Rabbit Air Purifiers Back In Stock at US Air Purifiers LLC 2Health News:Rabbit Air Purifiers Back In Stock at US Air Purifiers LLC 3Health News:Don’t Let Daylight Savings Disrupt Your Child’s Sleep 2Health News:Topical BioMedics Hosts March Pain Management Webinar 2Health News:Topical BioMedics Hosts March Pain Management Webinar 3Health News:Topical BioMedics Hosts March Pain Management Webinar 4Health News:Topical BioMedics Hosts March Pain Management Webinar 5Health News:ASHA Applauds Launch of New WHO Campaign 2
... epidemic proportions in Gujarat according to the government there ... any part of flood-ravaged Surat.// ,Quoting the ... State Health Secretary Amarjit Singh, Delhi, said that all ... rodent samples for plague as well as for Hantavirus ...
... has ordered administrations of all 30 districts to collect Pepsi ... ,The officials were Thursday asked to send the ... department official. ,These would then be sent to ... not have testing facilities to confirm the presence of pesticides. ...
... the time that kids spend in exercise will not guarantee ... //Economist John Cawley of Cornell University and colleagues found in ... students taking part in physical education decreased from 42% in ... data on 37,000 teens in grades nine through 12. All ...
... highly sensitive to allergies in the first three years of ... ,Sabina Illi and colleagues at the University Children's Hospital, Munich, ... allergens in early life and the effect of the sensitization ... They had reported their findings in the latest issue of ...
... with their doctors and practice nurses every year, according to ... revealed that over 11 million appointments with the doctors were ... in UK last year. The problem is more prevalent in ... Midlands are just behind. The survey was conducted among 329 ...
... that a specific variety of adult stem ... or other// types of tissue depending on the response ... researchers found that mesenchymal stem cells, which are commonly ... from their local environment, allowing a transformation into different ...
Cached Medicine News:Health News:Babies Prone To Allergies More likely To Be Asthmatic 2Health News:Adult stem cells are sensitive to responses from the environment 2
With BareWire technology, the wire crosses the lesion first, independent of the filter and delivery catheter. All other actions, including filter placement and retrieval, balloon dilatations, and ste...
... been uniquely designed to fit the ... integrated networks spanning multi-facilities. From test ... and accounts receivable, Centricity Ultra facilitates ... All system modules are fully integrated ...
... IMMULITE 2500 is a high-throughput immunoassay ... ,of the IMMULITE 2000 with the important ... technology ,allows assays to be designed for ... times. ,This allows for critical assays such ...
... Dehydroepiandrosterone sulfate (DHEA-S) is the sulfate ester ... by enzymatic conversion of DHEA in adrenal ... C19 steroid secreted by the adrenal cortex, ... estrogen biosynthesis. DHEA possesses relatively weak androgenic ...
Medicine Products: